Literature DB >> 31850589

Letter: a 5-year long-term follow-up study after DAA treatment confirms a reduced HCC risk in a central European cohort of HCV patients with liver cirrhosis.

Friederike Ebel1, Katja Deterding2, Kerstin Port1, Bernhard Schlevogt3, Michael P Manns1,4,5, Benjamin Maasoumy1, Markus Cornberg1, Heiner Wedemeyer2,4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31850589     DOI： 10.1111/apt.15597

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  3 in total

1.  Declining Numbers of Hepatitis C Virus-Associated Liver Transplantations in Germany.

Authors:  Heiner Wedemeyer; Kerstin Herzer; Yvonne Serfert; Richard Taubert; Christian Trautwein; Dennis Eurich; Christian P Strassburg; Melanie Lang; Karl Heinz Weiss; Thomas Berg; Peter R Galle; Hauke Heinzow; Stefan Zeuzem
Journal:  Dtsch Arztebl Int       Date:  2021-11-19       Impact factor: 5.594

2.  HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta-analysis.

Authors:  Ian Lockart; Malcolm G H Yeo; Behzad Hajarizadeh; Gregory J Dore; Mark Danta
Journal:  Hepatology       Date:  2022-02-07       Impact factor: 17.298

3.  Comparison of liver biopsies before and after direct-acting antiviral therapy for hepatitis C and correlation with clinical outcome.

Authors:  Omar A Saldarriaga; Bradley Dye; Judy Pham; Timothy G Wanninger; Daniel Millian; Michael Kueht; Benjamin Freiberg; Netanya Utay; Heather L Stevenson
Journal:  Sci Rep       Date:  2021-07-15       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.